Mecolo P 750mcg/75mg Injection
By Mecolo P
Rx
1 Injection in a Vial

Composition
Methylcobalamin(750mcg) + Pregabalin(75mg)

Manufacturer - Novique Life Sciences
Plot Number 371, 2nd Floor Industrial Area Phase-2 Panchkula-(Haryana)

Expires on or after
October, 2025

liver
Mecolo P 750mcg/75mg Injection is generally considered safe for individuals with liver disease. The available data indicates that there may not be a requirement for adjusting the dosage of Mecolo P 750mcg/75mg Injection in patients with liver conditions. It is advisable to consult your doctor for personalized guidance and recommendations regarding the use of Mecolo P 750mcg/75mg Injection in relation to liver health.

kidney
Mecolo P 750mcg/75mg Injection should be used carefully in patients with kidney disease. Adjusting the dose may be necessary. Consult your doctor for guidance.

alcohol
Mecolo P 750mcg/75mg Injection can lead to increased drowsiness when combined with alcohol. It is advisable to be cautious about alcohol consumption while using this medication.

driving
Mecolo P 750mcg/75mg Injection may lead to reduced alertness, vision impairment, drowsiness, and dizziness. Avoid driving if you experience these effects.

pregnancy
Mecolo P 750mcg/75mg Injection may not be safe during pregnancy. Limited human studies and animal studies suggest potential harm to the developing baby. Your doctor will assess benefits versus risks before prescribing. Please consult your doctor.

breastfeeding
Mecolo P 750mcg/75mg Injection is likely unsafe during breastfeeding. Limited data indicates potential harm to the baby through breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹125
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024